Cargando…
Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia
Friedreich ataxia is a progressive neurodegenerative disease caused by the expansion of GAA trinucleotide repeats within the first intron of the FXN gene, which encodes frataxin. The pathophysiology of the disease is thought to be derived from the decrease of Fe-S cluster biogenesis due to frataxin...
Autores principales: | Zhao, Hongting, Li, Huihui, Hao, Shuangying, Chen, Jiping, Wu, Jing, Song, Chuanhui, Zhang, Meng, Qiao, Tong, Li, Kuanyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575096/ https://www.ncbi.nlm.nih.gov/pubmed/28852135 http://dx.doi.org/10.1038/s41598-017-10320-2 |
Ejemplares similares
-
Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia
por: Li, Kuanyu, et al.
Publicado: (2008) -
Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia
por: Xia, Haiyan, et al.
Publicado: (2012) -
Frataxin levels in peripheral tissue in Friedreich ataxia
por: Lazaropoulos, Michael, et al.
Publicado: (2015) -
Mitochondrion-Targeted Peptide SS-31 Inhibited Oxidized Low-Density Lipoproteins-Induced Foam Cell Formation through both ROS Scavenging and Inhibition of Cholesterol Influx in RAW264.7 Cells
por: Hao, Shuangying, et al.
Publicado: (2015) -
Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich’s ataxia
por: Hackett, Peter T., et al.
Publicado: (2022)